Unlocking H1R Selectivity: Tokyo University of Science Researchers Reveal Thermodynamic Secrets for Rational Drug Design

Researchers at Tokyo University of Science have made significant strides in advancing rational drug design by investigating the binding thermodynamics of the histamine H1 receptor (H1R). H1R, a subtype of G-protein-coupled receptors (GPCRs), is crucial for allergic reactions and various physiological processes. GPCRs represent a major family of cell surface proteins and are targets for over 30% of current drugs. While antihistamines target H1R, existing treatments often come with limitations.

Recent advancements in rational drug design highlight the importance of not only binding affinity but also deeper thermodynamic components like enthalpy and entropy. The principle of enthalpy-entropy compensation, in particular, is recognized as key for achieving ligand selectivity. However, direct experimental measurement of these intricate parameters has historically been challenging for cell surface proteins such as GPCRs.

A Breakthrough Study in H1R Thermodynamics

A dedicated team led by Professor Mitsunori Shiroishi, alongside Mr. Hiroto Kaneko and Associate Professor Tadashi Ando, tackled this challenge directly. They systematically studied H1R binding thermodynamics to bridge this knowledge gap. Their groundbreaking findings have been officially published in ACS Medicinal Chemistry Letters.

"A team led by Professor Mitsunori Shiroishi, including Mr. Hiroto Kaneko and Associate Professor Tadashi Ando, addressed this by systematically studying H1R binding thermodynamics."

The team focused their investigation on the thermodynamic signatures of doxepin's E- and Z-geometric isomers when binding to H1R. H1R was prepared using an innovative budding yeast expression system. The researchers employed a combination of isothermal titration calorimetry (ITC) and molecular dynamics (MD) simulations to gather their data. Doxepin, known as both an antidepressant and a potent antihistamine, naturally exists as a mixture of these isomers. Previous research had indicated that the Z-isomer possesses a five-fold higher affinity for H1R, a difference specifically linked to a particular threonine residue (Thr1123.37).

To precisely elucidate this selectivity, the researchers meticulously synthesized a wild-type H1R (H1R_WT) and a T1123.37V mutant, where the Thr1123.37 residue was strategically swapped. They then rigorously tested the interactions of these receptor variants with doxepin and its individual E- and Z-isomers.

Key Thermodynamic Insights Unveiled

The detailed analysis yielded several critical findings:

• Binding energies of doxepin to H1R_WT and the T1123.37V mutant were similar, but enthalpic and entropic contributions differed significantly.
• H1R_WT binding was primarily enthalpy-driven. In contrast, the mutant receptor demonstrated a reduced enthalpic contribution coupled with an increased entropic contribution.
• The Z-isomer's binding to H1R_WT involved a larger enthalpic gain and a greater entropic penalty compared to the E-isomer. Notably, these specific differences were not observed in the T1123.37V mutant.
• The Z-isomer consistently displayed higher binding energy for H1R_WT, while both isomers exhibited comparable binding energies for the mutant, which aligns with earlier research findings.
• Thr1123.37 plays a crucial role in balancing enthalpic gains and entropic losses during ligand binding, with a more significant effect observed in Z-isomer interactions.

Molecular Dynamics Reveals Conformational Control

Further insights were gained through molecular dynamics simulations. These simulations revealed that the Z-isomer's high-affinity binding is intrinsically linked to conformational restrictions within the binding pocket. This finding provides a mechanistic explanation, aligning perfectly with the experimentally observed high enthalpy and reduced entropy during the Z-isomer's binding.

Implications for Rational Drug Design

Professor Shiroishi emphasized the broader impact of these discoveries. "Professor Shiroishi noted that these insights into the enthalpy-entropy trade-off in GPCR-ligand interactions underscore the importance of considering conformational constraints and flexibility in designing ligands with optimized thermodynamic properties."

This pioneering research holds immense potential to facilitate the development of new drugs with enhanced selectivity, leading to reduced off-target side effects and potentially more prolonged therapeutic effects. The innovative approach, which seamlessly combines detailed thermodynamic analysis with advanced molecular dynamics simulations, is highly applicable to a wide range of other GPCRs and proteins, thereby bolstering the field of rational drug design.

"The study suggests that subtle molecular conformations can influence the entropy-enthalpy balance, and understanding these principles can lead to the design of effective therapeutics with reduced off-target effects and improved efficacy across various protein-drug interactions."